New Leaf Venture Partners
New York City, New Yorknlvpartners.com
Overview
New Leaf Venture Partners is an early and growth-stage investor exclusively focused on healthcare technology. They invest across four sectors of healthcare technology: biopharmaceuticals, information convergence, medical devices, and life science tools. In Biopharmaceuticals, they invest from seed (creation) stage through to IPO and beyond. In Information Convergence (which includes healthcare IT, tools, and diagnostics) they invest from early stages through to companies with revenues of $100m+. They have a similar approach in Medical Devices and Life Sciences.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BrightInsight | Jan 2026 | VC Round | Co-investor |
| Electra Therapeutics | Oct 2025 | Series C | Co-investor |
| Abcuro | Feb 2025 | Series C | Co-investor |
| Truveris | May 2024 | Series E | Lead |
| Qlaris Bio | Apr 2024 | Series B | Lead |
Key People
Linda Ledecky
Investing Partner And Vice President Of Corporate Development
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.